Ann Arbor's NanoBio brings in $12 million in venture capital

Thursday, February 26, 2009 | Source: Concentrate
Despite the start-up's name, Ann Arbor's NanoBio isn't so small anymore with $12 million in new financing.

Excerpt:

NanoBio is attracting some big investment these days. The Ann Arbor-based firm just secured $12 million in new financing to help develop the company, bringing the total amount invested to $80 million.

The 3-year-old firm, University of Michigan spin-off, employs about 20 people and a handful of interns. It has hired several ex-Pfizer people after the pharmaceutical giant closed the doors to its Ann Arbor campus in 2007.

Read the rest of the story here.
Enjoy this story? Sign up for free solutions-based reporting in your inbox each week.

Related Tags

Biotechnology, Healthcare, Higher Education, Investment, University Of Michigan - Dearborn 

Recommended Content

Related Company

  • NanoBio
    2311 Green Road, Suite A
    Ann Arbor, MI 48105 Website
    NanoBio Corporation is a biopharmaceutical company founded by U-M faculty and focused on developing and commercializing anti-infective products and vaccines. With millions in investment and a half dozen products in the pipeline, they are an Ann Arbor ...
Sponsored By
Regions
Focus Areas
Copyright © Issue Media Group. All rights reserved.